Biohit Oyj Stock: price and insider trades · Finland

This page follows insider dealings at Biohit Oyj as filed with Nasdaq Helsinki, a company from the Health Care sector based in Helsinki, Finland. The group dates from 1988. The last twelve months, up to 18 October 2026, brought 6 filings signed by 2 insiders.

On the market, 1 insider bought (3 purchases totalling €4.4M) while 1 insider sold (3 sales totalling €4.4M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €2.4M, bought by Interlab Oy and made public on 1 December 2025 (6.8% of market cap).

With 6 filings in twelve months, the company is quieter than the median of 15 filings across the 126 companies we follow on the same exchange. Our records for Biohit Oyj go back to 2022, with 4 purchases and 4 sales on the open market in total.

The last insider purchase was made public on 4 December 2025, 317 days ago. Between a trade and the moment it shows up on Nasdaq Helsinki, the median delay is 2 days. The legal deadline for notifying a trade is three business days (MAR article 19).

Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by Nasdaq Helsinki. They describe what insiders did and are not a recommendation.